![FDA approves 1st automated, tubeless insulin pump for people with Type 1 diabetes - Good Morning America FDA approves 1st automated, tubeless insulin pump for people with Type 1 diabetes - Good Morning America](https://s.abcnews.com/images/GMA/insulet-omnipod-main-ht-jt-220121_1642797775990_hpMain_16x9_1600.jpg)
FDA approves 1st automated, tubeless insulin pump for people with Type 1 diabetes - Good Morning America
![A Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control: Trends in Endocrinology & Metabolism A Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control: Trends in Endocrinology & Metabolism](https://www.cell.com/cms/attachment/2d38dfa4-5b35-42f9-b434-b26fb99892f6/gr1.jpg)
A Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control: Trends in Endocrinology & Metabolism
![Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial - The Lancet Diabetes & Endocrinology Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/dda666be-7a17-4f5d-a5d3-c6156fdff534/gr1.gif)
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial - The Lancet Diabetes & Endocrinology
![The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019 | Diabetes Technology & Therapeutics The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019 | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2019.2525.abstracts/asset/images/medium/inline1.gif)